• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

What is the Value of Repeat Midtrimester Ultrasound after an Incomplete Scan?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • NICHD recommends 18 to 20 weeks as an ideal time for obstetric ultrasound for fetal anatomy while ISUOG recommends 18 to 22
  • Visualization of all required structures may not always be possible
    • Clinical utility and cost-effectiveness of repeat ultrasound to complete the initial evaluation has not been evaluated
  • NICHD recommend follow up in 2 to 4 weeks for limited visualization, but if the repeat exam is still incomplete

…the panel agreed that further ultrasonographic examination solely for better visualization is not recommended and should be performed only if there are other indications

  • Wood et al. (Amer J Perinatol, 2018) assessed the clinical utility of repeat ultrasound following an incomplete fetal anatomic survey

METHODS:

  • Retrospective cohort study
    • Midtrimester anatomic ultrasound
    • Singletons
    • Incomplete ultrasound with repeat exams until completion
  • Patients were divided based on when the exam was deemed completed
    • FIRST exam
    • SECOND exam
    • THIRD exam
  • The number of ultrasounds needed to detect an anomaly was assessed per group

RESULTS:

  • 15,768 ultrasounds were performed on 13,740 patients
    • 11,828 (86%) exams were completed on first attempt
      • Mean GA: 18.5 weeks
    • 1,796 (13%) required a second scan
      • Mean GA: 19.7 weeks
    • 116 (1%) required a third scan or more
      • Mean GA: 20.4 weeks
    • With increasing number of scans, patients were statistically more likely (p<0.001) to have the following
      • Demographics: Older | Black |Government insured
      • Comorbidities: Obesity | Progestational diabetes | Chronic hypertension
    • 324 total anomalies were detected
      • 93.8% in FIRST
      • 5.9% in SECOND
      • 0.3% in THIRD
    • The number of scans needed to detect an anomaly was
      • 39 in the FIRST
      • 189 in the SECOND
      • 348 in the THIRD
    • Overall, the system in which an anomaly was found was usually the same system that was not well seen on the initial evaluation (p = 0.044), especially for
      • Head | Face | Spine | Chest | Heart

CONCLUSION:

  • 94% of anomalies are detected in the initial fetal anatomic survey
  • The incremental diagnostic yield then decreases, requiring appreciably more repeat scans to detect one anomaly
  • The authors state

…given the limited yield for anomaly detection and considering health care resources, we suggest that the use of repeat midtrimester ultrasound for anomaly detection—particularly the use of more than one repeat ultrasound—should be minimized.

Learn More – Primary Sources:

The Utility of Repeat Midtrimester Anatomy Ultrasound for Anomaly Detection

Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop.

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Practical obstetrics info for your women's healthcare practice
When LMP and Ultrasound Dates Don’t Match: When to Redate?
Practical obstetrics info for your women's healthcare practice
Mild Cerebral Ventriculomegaly on Prenatal Ultrasound – Next Steps and Clinical Implications

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site